Measuring windows of selection for anti-malarial drug treatments

Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling

(2014) Eva Maria Hodel et al.   MALARIA JOURNAL

Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients

(2013) Eva Staehli Hodel et al.   MALARIA JOURNAL

Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance

(2013) JONATHAN M. MWANGI et al.   PARASITOLOGY

Improving Pharmacokinetic-Pharmacodynamic Modeling to Investigate Anti-Infective Chemotherapy with Application to the Current Generation of Antimalarial Drugs

(2013) Katherine Kay et al.   PLoS Computational Biology

Development, Evaluation, and Application of anIn SilicoModel for Antimalarial Drug Treatment and Failure

(2011) Katherine Winter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Residual Antimalarial Concentrations before Treatment in Patients with Malaria from Cambodia: Indication of Drug Pressure

(2010) Eva Maria Hodel et al.   JOURNAL OF INFECTIOUS DISEASES

How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance

(2010) Ian Hastings   TRENDS IN PARASITOLOGY

Residual Antimalarials in Malaria Patients from Tanzania – Implications on Drug Efficacy Assessment and Spread of Parasite Resistance

(2009) Eva Maria Hodel et al.   PLoS One

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment

(2009) W. E. Harrington et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug Resistance

(2008) K. Stepniewska et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY